Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Boffa

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Scientific Reports|April 20, 2024
Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13Hasam Madarati, Veronica DeYoung, Kanwal Singh, et al.
Current Problems in Cancer|February 21, 2018
IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophagesHossam Taha Mohamed, Noura El-Husseiny, Eslam A El-Ghonaimy, et al.
Blood|September 15, 2007
Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysisMichael B Boffa, Deborah Maret, Jeffrey D Hamill, et al.
JACC. Basic to Translational Science|October 5, 2020
Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve StenosisRaphaëlle Bourgeois, Romain Devillers, Nicolas Perrot, et al.
Frontiers in Cardiovascular Medicine|June 9, 2023
Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophagesMartina B Lorey, Amer Youssef, Lauri Äikäs, et al.
Atherosclerosis|June 8, 2023
High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific mannerJulia M Assini, Justin R Clark, Amer Youssef, et al.
Journal of Clinical Lipidology|January 19, 2025
Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform sizeAdedoyin Akinlonu, Michael B Boffa, Chen Lyu, et al.
Molecular Therapy. Methods & Clinical Development|November 16, 2022
<i>LPA</i> disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept studyAlexandria M Doerfler, So Hyun Park, Julia M Assini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2026
Cytosine base editing of LPA in transgenic mice averts large deletionsMarcel A Chuecos, So Hyun Park, Madhvi M Bhakta, et al.
Journal of Clinical Lipidology|April 2, 2024
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practiceMarlys L Koschinsky, Archna Bajaj, Michael B Boffa, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Scientific Reports|April 20, 2024
Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13Hasam Madarati, Veronica DeYoung, Kanwal Singh, et al.
Current Problems in Cancer|February 21, 2018
IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophagesHossam Taha Mohamed, Noura El-Husseiny, Eslam A El-Ghonaimy, et al.
Blood|September 15, 2007
Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysisMichael B Boffa, Deborah Maret, Jeffrey D Hamill, et al.
JACC. Basic to Translational Science|October 5, 2020
Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve StenosisRaphaëlle Bourgeois, Romain Devillers, Nicolas Perrot, et al.
Frontiers in Cardiovascular Medicine|June 9, 2023
Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophagesMartina B Lorey, Amer Youssef, Lauri Äikäs, et al.
Atherosclerosis|June 8, 2023
High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific mannerJulia M Assini, Justin R Clark, Amer Youssef, et al.
Journal of Clinical Lipidology|January 19, 2025
Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform sizeAdedoyin Akinlonu, Michael B Boffa, Chen Lyu, et al.
Molecular Therapy. Methods & Clinical Development|November 16, 2022
<i>LPA</i> disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept studyAlexandria M Doerfler, So Hyun Park, Julia M Assini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2026
Cytosine base editing of LPA in transgenic mice averts large deletionsMarcel A Chuecos, So Hyun Park, Madhvi M Bhakta, et al.
Journal of Clinical Lipidology|April 2, 2024
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practiceMarlys L Koschinsky, Archna Bajaj, Michael B Boffa, et al.
Pageof 8